Literature DB >> 21514341

Increased expression of NKX2.3 mRNA transcribed from the risk haplotype for ulcerative colitis in the involved colonic mucosa.

Takashi Arai1, Yoichi Kakuta, Yoshitaka Kinouchi, Tomoya Kimura, Kenichi Negoro, Hiroyuki Aihara, Katsuya Endo, Hisashi Shiga, Yoshitake Kanazawa, Masatake Kuroha, Rintaro Moroi, Hitoshi Nagasawa, Yosuke Shimodaira, Seiichi Takahashi, Tooru Shimosegawa.   

Abstract

NKX2.3 is a promising candidate for susceptibility genes to inflammatory bowel disease (IBD). The aim of this study was to perform a candidate gene analysis of NKX2.3 in Japanese IBD and to examine how the risk allele (haplotype) affects susceptibility to IBD using allelic expression ratios of NKX2.3 mRNA in the involved colonic mucosa. A total of 344 patients with Crohn's disease (CD), 253 patients with ulcerative colitis (UC), and 243 healthy controls (HCs) were genotyped for 3 tag-single nucleotide polymorphisms (SNPs; rs10883365, rs888208, and rs11596008) around NKX2.3. The allelic expression ratio of NKX2.3-mRNA was examined by TaqMan assay using rs888208 as an allelic (haplotypic) marker. Two SNPs (rs10883365 and rs888208) were significantly associated with UC (p = 7.79 × 10(-4), odds ratio [OR] = 1.54 [95% confidence interval (95% CI) 1.20-1.99], p = 7.70 × 10(-3), OR = 1.41 [95% CI 1.10-1.81], respectively) and 1 SNP (rs10883365) was associated with CD (p = 0.0366, OR = 1.29 [95% CI 1.02-1.63]). Haplotype B formed by the 3 SNPs demonstrated a significant association with UC (p = 6.11 × 10(-4), OR = 1.56 [95% CI 1.21-2.00]). Subgroup analyses indicated that rs10883365 was significantly associated mainly with colonic CD (p = 1.99 × 10(-3), OR = 1.91 [95% CI 1.27-2.88], vs HCs). The allelic expression ratios of NKX2.3 mRNA transcribed from haplotype B (risk haplotype) to haplotype A (the nonrisk haplotype) in the involved mucosa from 10 IBD patients were significantly higher than the allelic ratio of respective genomic DNA (p = 0.00195). We confirmed the association of SNP rs10883365 located in the 5' flanking region of NKX2-3 with Japanese UC and colonic CD and determined the risk haplotype (haplotype B) for UC. The demonstrated allelic expression imbalance supports the idea that the risk haplotype of NKX2.3 confers susceptibility to UC through increasing expression of NKX2.3 mRNA in the colonic mucosa.
Copyright © 2011 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21514341     DOI: 10.1016/j.humimm.2011.03.023

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  6 in total

Review 1.  Have genomic discoveries in inflammatory bowel disease translated into clinical progress?

Authors:  Adam V Weizman; Mark S Silverberg
Journal:  Curr Gastroenterol Rep       Date:  2012-04

2.  Genetic variants and monoallelic expression of surfactant protein-D in inflammatory bowel disease.

Authors:  Zhenwu Lin; Gerrit John; John P Hegarty; Arthur Berg; Wei Yu; Yunhua Wang; Ashley A Kelly; Blaise Z Peterson; Lisa S Poritz; Joanna Floros; Walter A Koltun
Journal:  Ann Hum Genet       Date:  2011-07-25       Impact factor: 1.670

Review 3.  Characteristics of Japanese inflammatory bowel disease susceptibility loci.

Authors:  Yoshiaki Arimura; Hiroyuki Isshiki; Kei Onodera; Kanna Nagaishi; Kentaro Yamashita; Tomoko Sonoda; Takayuki Matsumoto; Atsushi Takahashi; Masakazu Takazoe; Keiko Yamazaki; Michiaki Kubo; Mineko Fujimiya; Kohzoh Imai; Yasuhisa Shinomura
Journal:  J Gastroenterol       Date:  2013-08-13       Impact factor: 7.527

4.  Surgical resection of colorectal recurrence of gastric cancer more than 5 years after primary resection.

Authors:  Takehiro Noji; Yoshiyuki Yamamura; Jun Muto; Aki Kuroda; Junkichi Koinuma; Tatsuya Yoshioka; Katsuhiko Murakawa; Setsuyuki Otake; Satoshi Hirano; Koichi Ono
Journal:  Int J Surg Case Rep       Date:  2014-10-19

5.  Homeobox NKX2-3 promotes marginal-zone lymphomagenesis by activating B-cell receptor signalling and shaping lymphocyte dynamics.

Authors:  Eloy F Robles; Maria Mena-Varas; Laura Barrio; Sara V Merino-Cortes; Péter Balogh; Ming-Qing Du; Takashi Akasaka; Anton Parker; Sergio Roa; Carlos Panizo; Idoia Martin-Guerrero; Reiner Siebert; Victor Segura; Xabier Agirre; Laura Macri-Pellizeri; Beatriz Aldaz; Amaia Vilas-Zornoza; Shaowei Zhang; Sarah Moody; Maria Jose Calasanz; Thomas Tousseyn; Cyril Broccardo; Pierre Brousset; Elena Campos-Sanchez; Cesar Cobaleda; Isidro Sanchez-Garcia; Jose Luis Fernandez-Luna; Ricardo Garcia-Muñoz; Esther Pena; Beatriz Bellosillo; Antonio Salar; Maria Joao Baptista; Jesús Maria Hernandez-Rivas; Marcos Gonzalez; Maria Jose Terol; Joan Climent; Antonio Ferrandez; Xavier Sagaert; Ari M Melnick; Felipe Prosper; David G Oscier; Yolanda R Carrasco; Martin J S Dyer; Jose A Martinez-Climent
Journal:  Nat Commun       Date:  2016-06-14       Impact factor: 14.919

6.  Contribution of NKX2-3 polymorphisms to inflammatory bowel diseases: a meta-analysis of 35358 subjects.

Authors:  XiaoCheng Lu; Linjun Tang; Kai Li; JinYu Zheng; Penglai Zhao; Yi Tao; Li-Xin Li
Journal:  Sci Rep       Date:  2014-01-29       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.